PARAPROTEINAEMIA side effect
What is PARAPROTEINAEMIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PARAPROTEINAEMIA and Recently Reported Side Effects
PARAPROTEINAEMIA and 15 most Active Side Effect polls
PARAPROTEINAEMIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Remicade Side Effects Report #5513975-4
Health Professional from UNITED KINGDOM reported REMICADE problem on Nov 02, 2007. Female patient, weighting 125.7 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: paraproteinaemia, renal amyloidosis, . REMICADE dosage: unknown. During the same period patient was treated with SULFASALAZINE, METHOTREXATE, ASPIRIN, FOLIC ACID, FOSAMAX, NAPROXEN. Patient recovered.
Remicade Side Effects Report #5465495-3
REMICADE problem was reported by a Health Professional from UNITED KINGDOM on Sept 14, 2007. Female patient, weighting 125.7 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: paraproteinaemia, renal amyloidosis, . REMICADE dosage: unknown. During the same period patient was treated with SULFASALAZINE, METHOTREXATE, ASPIRIN, FOLIC ACID, FOSAMAX, NAPROXEN. Patient recovered.
Prograf Side Effects Report #5500631-1
Health Professional from UNITED STATES reported PROGRAF problem on Oct 11, 2007. Male patient, 67 years of age, weighting 145.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, paraproteinaemia, plasmacytoma, pleural effusion, . PROGRAF dosage: 5 MG, BID, ORAL. During the same period patient was treated with CELLCEPT, RAPAMYCIN. Patient died on 07/27/2007.
Remicade Side Effects Report #5416597-9
REMICADE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2007. Male patient, 58 years of age, weighting 145.0 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: non-hodgkin's lymphoma, paraproteinaemia, . REMICADE dosage: unknown. During the same period patient was treated with HUMIRA, ENBREL. Patient was hospitalized. Patient recovered.
Velcade Side Effects Report #5379570-5
Physician from AUSTRALIA reported VELCADE problem on June 19, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, paraproteinaemia, plasmapheresis, thrombocytopenia, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ROMIDEPSIN, DEXAMETHASONE, THALIDOMIDE, ACCUPRIL, MAGNESIUM ASPARTATE, NORVASC, ZOMETA, SEPTRINTE. Patient was hospitalized. Patient died on 05/10/2007.
Velcade Side Effects Report #5379570-5
VELCADE problem was reported by a Physician from AUSTRALIA on June 19, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, paraproteinaemia, plasmapheresis, thrombocytopenia, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ROMIDEPSIN, DEXAMETHASONE, THALIDOMIDE, ACCUPRIL, MAGNESIUM ASPARTATE, NORVASC, ZOMETA, SEPTRINTE. Patient was hospitalized. Patient died on 05/10/2007.
Velcade Side Effects Report #5788950-5
Consumer or non-health professional from UNITED KINGDOM reported VELCADE problem on June 11, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, paraproteinaemia, . VELCADE dosage: 1.3 MG/M2. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Velcade Side Effects Report #5284477-8
VELCADE problem was reported by a Physician from AUSTRALIA on Mar 16, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, paraproteinaemia, thrombocytopenia, . VELCADE dosage: unknown. During the same period patient was treated with ROMIDEPSIN, DEXAMETHASONE, THALIDOMIDE, ACCUPRIL, MAGNESIUM ASPARTATE, NORVASC, ZOMETA, SEPTRINTE. Patient was hospitalized. Patient recovered.
Campath Side Effects Report #5635548-5
Physician from AUSTRIA reported CAMPATH problem on Feb 18, 2008. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia, multiple myeloma and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, paraproteinaemia, pneumonia, . CAMPATH dosage: unknown. During the same period patient was treated with BENDAMUSTINE. Patient died on 09/30/2006.
Evista Side Effects Report #5583939-3
EVISTA problem was reported by a Physician from UNITED STATES on Dec 26, 2007. Female patient, 60 years of age, was diagnosed with osteopenia and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: gammopathy, paraproteinaemia, . EVISTA dosage: unknown. Patient recovered.
Evista Side Effects Report #5567870-5
Consumer or non-health professional from UNITED STATES reported EVISTA problem on Dec 10, 2007. Female patient, 60 years of age, was diagnosed with osteopenia and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: gammopathy, paraproteinaemia, . EVISTA dosage: unknown. Patient recovered.